Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
00:20
Greece's junior coalition partner, the Independent Greeks, will vote "with a heavy heart" to endorse government proposals submitted to creditors, party leader says.
Funny how they debate like they have options. Sounds like a bunch of democrats that are used to handouts! Time for some tough love, cause they been drinking that Kool-Aid for awhile!
Next 45 minutes of after market trading should be exciting!
23:37
Now the leader of the other party opposed to a deal with Europe - Dimitris Koutsoubas of the Communist KKE - is saying that a third bailout deal would be disastrous for Greece. He accuses Syriza of opportunism.
What is this guy smoking! Disaster for most common Greeks is no deal!
Last trade was $1.25. We move up from here! Opens Monday @ $1.45!!!
Better load up before the close, because we will hit 1.45 on Monday!!!
H.C. Wainwright (Rodman & Renshaw) initiated coverage on Second Sight Medical (NASDAQ: EYES) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Second Sight Medical click here. For more ratings news on Second Sight Medical click here.
Shares of Second Sight Medical closed at $14.05 yesterday.
Picked up another 500 shares on today's dip! I bought this down to $8.92 on 2/17/15, before the last big run. Nearly sold out on 3/5/15 @ $19.01. Held onto the 100 shares that I bought @ $21.665 on 11/19/14. Have bought and sold over 25K shares of this stock since the IPO!
I see the last trade (after market close) was $16.60. I expect to see some Form 4s come through in the weeks ahead. Very positive presentation today! They are still debt free and business looks good. All positive developments.
I bought on the pre-con dip! Now own 4500 shares. Listening to the live presentation now!
Looks like this is what they intend to present to investors tomorrow. It is a great story, so the PPS should continue to soar this week! Don't be so quick to sell, as I expect we will exceed $22/share by EOM!!!
I expect large block purchases after the conference. If Second Sight gets the visibility they deserve, the PPS will move up very quickly. We should move above the IPO price and potentially set a new 52-week high!
You should do some DD on their website.
http://www.secondsight.com/
They will be presenting Second Sight (EYES) to large investment firms who are looking to invest large sums of money in companies that they feel are a good investment. I don't expect any new announcements at this conference, but it could trigger large investments that would cause the stock to move significantly.
EYES just mentioned very favorably on Fox Business News, Making Money w/Charles Payne. Get ready for a run tomorrow!
Second Sight to Present at JMP Securities Life Sciences Conference
SYLMAR, Calif., June 16, 2015 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc.(EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that Dr. Robert Greenberg, President and Chief Executive Officer, will present at the JMP Securities Life Sciences Conference as follows:
Presentation Date: Wednesday, June 24, 2015
Presentation Time: 1:00 p.m. EDT
Location: St. Regis, New York City, NY
The presentation will be webcast live and can be accessed at the conference website, http://wsw.com/webcast/jmp27/eyes, or in the Investor Relations section of the Company's website, secondsight.com.
As I see it, "The smoker you drink, the player you get"! Don't play with the house's money! If you can't afford to lose, don't play this game. This is a high risk/reward play and somebody will get burnt! Let's see who blinks 1st????? The Germans have the money and the Greeks have seemingly nothing to loose. It reminds me of what the space between a rock and a hard place must look like. I'm betting with Greece!!!
I must be crazy like a fox, cause I bought 8.5K @ $1.24 this morning & sold @ $1.29 this afternoon! Played golf after the market closed. Life is good.....
Blue Earth: Insiders Prepare To Exit, 80% Downside
Blue Earth Insiders Prepare To Exit
Depends on what they present @ the conference! If it dips 4% or more from my last buy, I will buy again!
It was reported (8-K) on 5/14/15!
He was co-founder, with Kasia Zukowska. It appears she is still employed @ Ecrypt.
On May 12, 2015, Brad Lever resigned as the CFO and COO.
The dips are just noise! I use them as flipping opportunities. I'm confident we will see $22 by early next year. I bought 500 shares @ $13.9 and $13.4, then sold 500 shares @ $14.1. Have the other 500 shares up for sale @ $14.8. I currently hold 4K+ shares.
Bought another 1K shares today!!!
Bought another 1K shares today!!!
Weeeeee!
Sounds like speculation to me!
Why would I sell, I'm not the one complaining!
I'm only looking to add 300K @ this level, but will buy more if you want to wait until the price drops further. I use to have more than 4M shares, but sold some back @ .019. I'm looking to reload my .011 positions.
If you are not happy with your shares, I have an order for up to 300K @ .011. This is your chance to get out!
In my opinion, there is something very special about HHSE! I am proud to claim that we are long term investors. Bought my wife's (Roth IRA) 1st shares 3/13/07 and my (Roth IRA) 1st shares 3/16/07, as VPFI. It went from VPFI to TDGT in 07, then to TDGI in 09, before becoming HHSE in 2012.
It was from Hannover House.
Did you get your "Thank You" letter today, along with the HHSE Marketing tri-fold card?
My wife and I both got one! We are glad to be long term investors!
I bought more last week, so am currently holding over 4K shares! I like my chances of having a big payday! I see little downside risk at this level.
The Company outlined its plans for additional phase 2 clinical assessment, including a phase 2a dose expansion in 29 to 34 weeks gestational age infants to evaluate increased doses and repeat dosing, which is expected to begin in the second quarter of 2015 and be completed in the fourth quarter of 2015; a phase 2a clinical trial assessing the safety and tolerability of escalating doses of AEROSURF administered to 26 to 28 weeks gestational age infants, with an ability to administer repeat doses, which is expected to begin in July 2015 and be completed in the fourth quarter of 2015; and a phase 2b clinical trial to determine the optimal dose and define the expected efficacy margin of AEROSURF treatment, which is expected to begin in the fourth quarter of 2015 and be completed in mid 2016.
In addition, the Company reaffirms its forecast set forth in the Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, as follows: before any additional financings the Company anticipates that it will have sufficient cash available to support the AEROSURF clinical program as outlined in this Current Report on Form 8-K, pay debt service and fund its operations through the first quarter of 2016.
Alibaba Group's Tmall.com Partners With Walt Disney To Distribute Movie Merchandise For The First Time
Time for panic selling!
I have my buy orders waiting!
Bring on the cheapies!
Looks like we will open above $4.50.